Emergent Biosolutions, Inc. EBS
Key Stats
- Today's Range
- $7.20 – $7.42
- 50-Day Range
- $7.05 – $9.40
- 52-Week Range
- $5.62 – $14.06
- Volume
- 441K shs
- Average Volume
- 764K shs
- Market Cap
- $372.53 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 0.71
- Price / Sales
- 0.55
Short Interest
- Short Interest
- 2.38%
- Days to Cover
- 4.40
Financials (TTM)
- Revenue
- $676.80 million
- Net Income
- $-8,600,000
- Net Margin
- -1.27%
- Return on Equity
- -1.64%
- Debt-to-Equity
- 1.13
About Emergent Biosolutions, Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.